The global ablation technology market size is expected to advance at a CAGR of 8.9% during the forecast period. The demand for ablation technology is anticipated to hit USD 14.6 billion by 2034 from USD 6.2 billion in 2024.
The primary catalyst of the market’s growth is the global healthcare industry's technological developments. Due to the many benefits of minimally invasive procedures, such as shorter hospital stays, a decreased risk of infection, and more cosmetic incisions, the trend towards these procedures is rising, encouraging the expansion of the ablation technology market.
| Attributes | Details |
|---|---|
| Market Value for 2024 | USD 6.2 billion |
| Market Value for 2034 | USD 14.6 billion |
| CAGR (2024 to 2034) | 8.9% |
The ablation technologies market is impacted by the introduction of non-thermal, non-tumescent, and non-sclerosant endovenous ablation devices, as well as the rise in the incidence of chronic illnesses.
Technological advancements in medical equipment and healthcare and the growing awareness of the advantages of minimally invasive procedures have positively impacted the ablation technology market.
Developing next-generation ablation devices with robotic navigation systems strengthens profitable opportunities for ablation technology manufacturers.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market developed significantly from 2019 to 2023, propelled by technological improvements and a rise in the adoption of ablation technology in different medical settings.
Short-term Analysis (From 2019 to 2023)
The increased demand for medical procedures and technical advancements fostered a strong market expansion of ablation technology. Research and development experienced an upsurge in the ablation technology industry, creating a competitive environment with a wide range of healthcare applications.
| Attributes | Details |
|---|---|
| Market Value for 2019 | USD 3.7 billion |
| Market Value for 2023 | USD 5.7 billion |
| Market CAGR from 2019 to 2023 | 10.9% |
Mid-term Analysis (From 2024 to 2028)
Ablation technology is set to become more integral to medical interventions due to anticipated developments in the field. Improved accuracy, more applications, and greater interaction with other medical technologies are expected to drive market growth. The growing awareness and regulatory support ought to maintain market momentum.
Long-term Analysis (From 2028 to 2033)
Ablation technology is anticipated to transform into a key element of minimally invasive operations in the long run, helping to change how medical interventions are thought of. A revolutionary influence on healthcare practices is stimulated by ongoing technological innovation and enhanced accessibility, accelerating market penetration.
Age-related health problems are more likely to arise due to the aging population, which encourages demand for ablation technology. Interventions are frequently needed to control and treat various medical issues in older adults.
Ongoing developments aid market expansion in ablation technologies, such as new approaches to procedures, imaging modalities, and energy sources. These developments draw patients and healthcare professionals alike by improving ablation treatments' accuracy, security, and effectiveness.
Market expansion of ablation technology is facilitated by rising patient and healthcare professional knowledge of the advantages of ablation treatments. Programs for education and training are essential for increasing the body of knowledge and promoting the adoption of ablation technologies.
Principal Consultant
Based on the segmented market research of ablation technology, the industry leader in the application category is the cardiovascular disease treatment sector. A thorough investigation shows radiofrequency ablators are leading the product category.
Sales of radiofrequency ablators are expected to accelerate at a CAGR of 8.6% through 2034.
| Top Product | Radiofrequency Ablators |
|---|---|
| CAGR (2024 to 2034) | 10.7% |
Major trends driving demand for radiofrequency ablators are:
The demand for cardiovascular disease treatments segment is expected to flourish at a CAGR of 8.4% through 2034.
| Top Application | Cardiovascular Disease Treatment |
|---|---|
| CAGR (2024 to 2034) | 10.5% |
The application of ablation technology for cardiovascular illness is progressing as heart problems become prevalent and require novel and efficient treatment alternatives. Cardiovascular applications are prominent in the ablation technology market due to the growing knowledge of and acceptance of less invasive procedures. The significance of cardiovascular applications that propel market leadership is highlighted by the urgent demand for better patient outcomes and shorter recovery times.
The market analysis of ablation technology is portrayed in the following tables, which highlight the significant economies of Asia Pacific, Europe, and North America.
An in-depth evaluation shows a lot of potential in Japan due to the presence of several manufacturers of ablation technology. Resilient ablation technology suppliers highlight Japan's market potential and promote the nation as a lucrative hub for developments and expansion in the ablation technology field.
| Country | CAGR (2024 to 2034) |
|---|---|
| Japan | 10.6% |
| United Kingdom | 9.8% |
| China | 9.7% |
| United States | 9.3% |
| South Korea | 6.7% |
The demand for ablation technology is driven by an aging population and a high frequency of chronic diseases, making Japan an important player in the Asia Pacific market. The demand for ablation technology in Japan exhibited an HCAGR of 13.4% from 2019 to 2023.
Japan's ablation technology market is rising because of the country's growing inclination for less intrusive procedures and innovative medical technologies. The ablation technology market is growing due to strategic partnerships between Japanese businesses and global companies that enable the sharing of technological expertise.
In the United Kingdom, the demand for ablation technology has steadily increased due to rising chronic illness incidences and a proactive attitude toward healthcare innovations. The United Kingdom market developed at a CAGR of 13.3% through 2023.
A well-established healthcare system and high levels of technological adoption have created an advanced market for ablation technology in the United Kingdom. The United Kingdom's reimbursement practices and regulatory frameworks provide patients access to advanced medical treatments by creating a stable environment for the growth of ablation technology.
Due to rising healthcare expenditures and a growing middle class, China is leading globally in ablation technology market growth. Sales of ablation technology evolved at an CAGR of 12.4% from 2019 to 2023.
An aging population and an increase in the prevalence of cardiovascular illnesses are pushing demand for ablation technology, making China a major player in the ablation technology industry. Initiatives for localized research and development help to innovate and tailor ablation technology to China's unique medical demands.
The United States ablation technology market surged at an HCAGR of 11.6% from 2019 to 2023. Due to its robust healthcare infrastructure and significant healthcare expenditures, the United States is a leader in the adoption of ablation technology.
The United States ablation technology industry is growing due to rising chronic illness prevalence and proactive regulations. The ablation technology industry in the United States is constantly expanding due to generous reimbursement guidelines and a strong emphasis on technology developments.
Sales of ablation technology in South Korea thrusted at a strong HCAGR of 18.4% during the historical period. The adoption of ablation technology continues to grow in South Korea due to a greater understanding of the advantages of minimally invasive procedures.
The market growth for ablation technology in South Korea is centered on government programs that support the development of healthcare infrastructure and the acceptance of new technologies. In South Korea, an emphasis on teaching medical practitioners how to use ablation technology improves its acceptance and application across various specializations.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Prominent Ablation Technology ManufacturersThe market is competitive, with a wide selection of ablation technology vendors providing innovative solutions. Major ablation technology providers concentrate on research and development, tactical alliances, and technology breakthroughs to obtain a competitive edge.
The rising incidence of chronic diseases and the growing desire for minimally invasive procedures stimulate market growth for ablation technology.
The leaders in the field promote innovation and direct the development of ablation technology. Manufacturers of ablation technology at the forefront include Boston Scientific Corporation and Medtronic Plc., while Abbott Laboratories and Johnson & Johnson offer distinctive strengths. Olympus Corporation, Varian Medical Systems Inc., and EDAP TMS S.A. provide various solutions and play crucial roles. The participants continuously mold the market's evolution by advancing the boundaries of ablation technology.
Notable Strides
| Company | Details |
|---|---|
| Medtronic | For patients with atrial fibrillation, Medtronic finished recruiting subjects for a pivotal trial that assessed a revolutionary pulsed field ablation catheter in December 2022. |
| Medtronic | To foster quick innovation in stroke treatment, Medtronic announced the launch of the Medtronic Neurovascular Co-LabTM Platform in October 2022. |
| Olympus Corporation | In October 2022, EU-ME3, an endoscopic ultrasound processor, was launched by Olympus Corporation, a global MedTech company committed to improving people's lives through health, safety, and fulfillment. This device was created to satisfy the demands of medical professionals seeking clear, high-quality images when performing endoscopic ultrasound procedures. Europe, the Middle East, Africa, Asia, and Oceania are likely to have access to EU-ME3 during this fiscal year. EU-ME3 is displayed from October 8 to October 11 at the 30th United European Gastroenterology Week. |
| PENTAX Medical | The C2 CryoBalloon Ablation System was released in Canada in October 2022 to treat Barrett's esophagus. PENTAX Medical, a producer of endoscopic instruments for therapeutic and diagnostic uses, carried this out. |
| Quantum Surgical | In March 2022, the United States Food and Drug Administration approved Quantum Surgical's 510(k) for their Epione robot, which can design, perform, and confirm tumor ablation as a cancer treatment. |
The ablation technology market is estimated to secure a valuation of USD 6.2 billion in 2024.
The ablation technique market is estimated to reach USD 14.6 billion by 2034.
The ablation technology industry is anticipated to develop at an 8.9% CAGR through 2034.
From 2019 to 2023, the ablation device market recorded a CAGR of 10.9%.
The radiofrequency ablators segment is anticipated to dominate the market, exhibiting a CAGR of 8.6% from 2024 to 2034.
The cardiovascular disease treatment segment is likely to accelerate at a CAGR of 8.4% through 2034.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Radiofrequency Ablators 5.1.1. Temperature-Controlled Radiofrequency Ablators 5.1.2. Fluid-Cooled Radiofrequency Ablators 5.1.3. Robotic Catheter Manipulation Systems 5.2. Laser/Light Ablators 5.2.1. Excimer Laser Ablators 5.2.2. Cold Laser Ablators 5.3. Ultrasound Ablators 5.3.1. Ultrasonic Surgical Ablation Systems 5.3.2. High-Intensity Focused Ultrasound Ablators 5.3.3. Extracorporeal Shockwave Lithotripsy Systems 5.3.4. Magnetic Resonance-Guided Focused Ultrasound Ablators 5.4. Electrical Ablators 5.4.1. Argon Plasma/Beam Coagulators 5.4.2. Irreversible Electroporation Ablators 5.5. Cryoablation Devices 5.5.1. Tissue Contact Probes 5.5.2. Tissue Spray Probe 5.5.3. Epidermal & Subcutaneous Cryoablation Devices 5.6. Microwave Ablators 5.7. Hydrothermal/Hydromechanical Ablators 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Cardiovascular Disease Treatment 6.2. Cancer Treatment 6.2.1. Liver Cancer 6.2.2. Kidney Cancer 6.2.3. Prostate Cancer 6.2.4. Lung Cancer 6.2.5. Bone Metastasis 6.2.6. Breast Cancer 6.3. Ophthalmological Treatment 6.4. Pain Management 6.5. Urological Treatment 6.6. Orthopedic Treatment 6.7. Cosmetic/ Aesthetic Surgery 6.8. Gynecological Treatment 6.9. Others 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-Use 7.1. Hospitals 7.2. Ambulatory Surgical Centers 7.3. Ablation Centers 7.4. Others 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Medtronic 18.2. Johnson & Johnson Private Limited 18.3. Abbott 18.4. Boston Scientific Corporation 18.5. AngioDynamics 18.6. ATRICURE 18.7. CONMED Corporation 18.8. Olympus Corporation 18.9. Smith+Nephew 18.10. Stryker 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Ablation Technology Market
